Tandem Diabetes Care
TNDM
#4256
Rank
A$3.16 B
Marketcap
$48.20
Share price
4.38%
Change (1 day)
71.77%
Change (1 year)
Categories

P/E ratio for Tandem Diabetes Care (TNDM)

P/E ratio as of November 2024 (TTM): -9.33

According to Tandem Diabetes Care 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -9.33436. At the end of 2022 the company had a P/E ratio of -30.6.

P/E ratio history for Tandem Diabetes Care from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-30.6-104.88%
2021627-480.18%
2020-16521.77%
2019-1351166.64%
2018-10.77214.82%
2017-0.1462-81.41%
2016-0.7867-83.15%
2015-4.6725.7%
2014-3.71-45.95%
2013-6.87

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
155-1,760.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-83.0 788.82%๐Ÿ‡บ๐Ÿ‡ธ USA
76.8-922.50%๐Ÿ‡บ๐Ÿ‡ธ USA
30.9-431.28%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
10.9-216.45%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.